Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Akoya Biosciences Inc

AKYA
Current price
4.84 USD +0.18 USD (+3.86%)
Last closed 4.72 USD
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 231 639 648 USD
Yield for 12 month -61.43 %
Week
Month
Year
AKYA
21.11.2021 - 28.11.2021

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts. Address: 100 Campus Drive, Marlborough, MA, United States, 01752

Analytics

WallStreet Target Price

10.38 USD

P/E ratio

Dividend Yield

Current Year

+74 859 000 USD

Last Year

+54 917 000 USD

Current Quarter

+25 215 000 USD

Last Quarter

+23 521 000 USD

Current Year

+43 390 000 USD

Last Year

+34 218 000 USD

Current Quarter

+15 276 000 USD

Last Quarter

+12 116 000 USD

Key Figures AKYA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -55 619 000 USD
Operating Margin TTM -44.77 %
PE Ratio
Return On Assets TTM -22.73 %
PEG Ratio
Return On Equity TTM -104.18 %
Wall Street Target Price 10.38 USD
Revenue TTM 91 365 000 USD
Book Value 1.26 USD
Revenue Per Share TTM 2.2 USD
Dividend Share
Quarterly Revenue Growth YOY 33.8 %
Dividend Yield
Gross Profit TTM 43 390 000 USD
Earnings Share -1.73 USD
Diluted Eps TTM -1.73 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin -78.14 %

Dividend Analytics AKYA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AKYA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation AKYA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 2.4968
Price Sales TTM 2.5353
Enterprise Value EBITDA -4.1964
Price Book MRQ 3.7377

Financials AKYA

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators AKYA

For 52 weeks

3.04 USD 13.25 USD
50 Day MA 4.01 USD
Shares Short Prior Month 1 206 392
200 Day MA 6.29 USD
Short Ratio 8.27
Shares Short 986 053
Short Percent 3.14 %